Identification of novel HLA-A∗24: 02-restricted epitope derived from a homeobox protein expressed in hematological malignancies

Maiko Matsushita, Yohei Otsuka, Naoya Tsutsumida, Chiaki Tanaka, Akane Uchiumi, Koji Ozawa, Takuma Suzuki, Daijyu Ichikawa, Hiroyuki Aburatani, Shinichiro Okamoto, Yutaka Kawakami, Yutaka Hattori

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The homeobox protein, PEPP2 (RHOXF2), has been suggested as a cancer/testis (CT) antigen based on its expression pattern. However, the peptide epitope of PEPP2 that is recognized by cytotoxic T cells (CTLs) is unknown. In this study, we revealed that PEPP2 gene was highly expressed in myeloid leukemia cells and some other hematological malignancies. This gene was also expressed in leukemic stem-like cells. We next identified the first reported epitope peptide (PEPP2271-279). The CTLs induced by PEPP2271-279 recognized PEPP2-positive target cells in an HLA-A∗24:02-restricted manner. We also found that a demethylating agent, 5-aza-2′-deoxycytidine, could enhance PEPP2 expression in leukemia cells but not in blood mononuclear cells from healthy donors. The cytotoxic activity of anti-PEPP2 CTL against leukemic cells treated with 5-aza-2′-deoxycytidine was higher than that directed against untreated cells. These results suggest a clinical rationale that combined treatment with this novel antigen-specific immunotherapy together with demethylating agents might be effective in therapy-resistant myeloid leukemia patients.

Original languageEnglish
Article numbere0146371
JournalPLoS One
Volume11
Issue number1
DOIs
Publication statusPublished - 2016 Jan 1

Fingerprint

HLA-A24 Antigen
decitabine
homeodomain proteins
Homeodomain Proteins
T-cells
Hematologic Neoplasms
epitopes
Epitopes
Myeloid Leukemia
Genes
T-Lymphocytes
Antigens
Peptides
myeloid leukemia
cells
T-lymphocytes
Testicular Neoplasms
Blood
Myeloid Cells
Immunotherapy

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Identification of novel HLA-A∗24 : 02-restricted epitope derived from a homeobox protein expressed in hematological malignancies. / Matsushita, Maiko; Otsuka, Yohei; Tsutsumida, Naoya; Tanaka, Chiaki; Uchiumi, Akane; Ozawa, Koji; Suzuki, Takuma; Ichikawa, Daijyu; Aburatani, Hiroyuki; Okamoto, Shinichiro; Kawakami, Yutaka; Hattori, Yutaka.

In: PLoS One, Vol. 11, No. 1, e0146371, 01.01.2016.

Research output: Contribution to journalArticle

Matsushita, Maiko ; Otsuka, Yohei ; Tsutsumida, Naoya ; Tanaka, Chiaki ; Uchiumi, Akane ; Ozawa, Koji ; Suzuki, Takuma ; Ichikawa, Daijyu ; Aburatani, Hiroyuki ; Okamoto, Shinichiro ; Kawakami, Yutaka ; Hattori, Yutaka. / Identification of novel HLA-A∗24 : 02-restricted epitope derived from a homeobox protein expressed in hematological malignancies. In: PLoS One. 2016 ; Vol. 11, No. 1.
@article{6748ba0c190e412eab255dc1e615f851,
title = "Identification of novel HLA-A∗24: 02-restricted epitope derived from a homeobox protein expressed in hematological malignancies",
abstract = "The homeobox protein, PEPP2 (RHOXF2), has been suggested as a cancer/testis (CT) antigen based on its expression pattern. However, the peptide epitope of PEPP2 that is recognized by cytotoxic T cells (CTLs) is unknown. In this study, we revealed that PEPP2 gene was highly expressed in myeloid leukemia cells and some other hematological malignancies. This gene was also expressed in leukemic stem-like cells. We next identified the first reported epitope peptide (PEPP2271-279). The CTLs induced by PEPP2271-279 recognized PEPP2-positive target cells in an HLA-A∗24:02-restricted manner. We also found that a demethylating agent, 5-aza-2′-deoxycytidine, could enhance PEPP2 expression in leukemia cells but not in blood mononuclear cells from healthy donors. The cytotoxic activity of anti-PEPP2 CTL against leukemic cells treated with 5-aza-2′-deoxycytidine was higher than that directed against untreated cells. These results suggest a clinical rationale that combined treatment with this novel antigen-specific immunotherapy together with demethylating agents might be effective in therapy-resistant myeloid leukemia patients.",
author = "Maiko Matsushita and Yohei Otsuka and Naoya Tsutsumida and Chiaki Tanaka and Akane Uchiumi and Koji Ozawa and Takuma Suzuki and Daijyu Ichikawa and Hiroyuki Aburatani and Shinichiro Okamoto and Yutaka Kawakami and Yutaka Hattori",
year = "2016",
month = "1",
day = "1",
doi = "10.1371/journal.pone.0146371",
language = "English",
volume = "11",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "1",

}

TY - JOUR

T1 - Identification of novel HLA-A∗24

T2 - 02-restricted epitope derived from a homeobox protein expressed in hematological malignancies

AU - Matsushita, Maiko

AU - Otsuka, Yohei

AU - Tsutsumida, Naoya

AU - Tanaka, Chiaki

AU - Uchiumi, Akane

AU - Ozawa, Koji

AU - Suzuki, Takuma

AU - Ichikawa, Daijyu

AU - Aburatani, Hiroyuki

AU - Okamoto, Shinichiro

AU - Kawakami, Yutaka

AU - Hattori, Yutaka

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The homeobox protein, PEPP2 (RHOXF2), has been suggested as a cancer/testis (CT) antigen based on its expression pattern. However, the peptide epitope of PEPP2 that is recognized by cytotoxic T cells (CTLs) is unknown. In this study, we revealed that PEPP2 gene was highly expressed in myeloid leukemia cells and some other hematological malignancies. This gene was also expressed in leukemic stem-like cells. We next identified the first reported epitope peptide (PEPP2271-279). The CTLs induced by PEPP2271-279 recognized PEPP2-positive target cells in an HLA-A∗24:02-restricted manner. We also found that a demethylating agent, 5-aza-2′-deoxycytidine, could enhance PEPP2 expression in leukemia cells but not in blood mononuclear cells from healthy donors. The cytotoxic activity of anti-PEPP2 CTL against leukemic cells treated with 5-aza-2′-deoxycytidine was higher than that directed against untreated cells. These results suggest a clinical rationale that combined treatment with this novel antigen-specific immunotherapy together with demethylating agents might be effective in therapy-resistant myeloid leukemia patients.

AB - The homeobox protein, PEPP2 (RHOXF2), has been suggested as a cancer/testis (CT) antigen based on its expression pattern. However, the peptide epitope of PEPP2 that is recognized by cytotoxic T cells (CTLs) is unknown. In this study, we revealed that PEPP2 gene was highly expressed in myeloid leukemia cells and some other hematological malignancies. This gene was also expressed in leukemic stem-like cells. We next identified the first reported epitope peptide (PEPP2271-279). The CTLs induced by PEPP2271-279 recognized PEPP2-positive target cells in an HLA-A∗24:02-restricted manner. We also found that a demethylating agent, 5-aza-2′-deoxycytidine, could enhance PEPP2 expression in leukemia cells but not in blood mononuclear cells from healthy donors. The cytotoxic activity of anti-PEPP2 CTL against leukemic cells treated with 5-aza-2′-deoxycytidine was higher than that directed against untreated cells. These results suggest a clinical rationale that combined treatment with this novel antigen-specific immunotherapy together with demethylating agents might be effective in therapy-resistant myeloid leukemia patients.

UR - http://www.scopus.com/inward/record.url?scp=84958205852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958205852&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0146371

DO - 10.1371/journal.pone.0146371

M3 - Article

C2 - 26784514

AN - SCOPUS:84958205852

VL - 11

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 1

M1 - e0146371

ER -